Kim SH - Search Results

1

IL7-Fc Enhances the Efficacy of Adoptive T Cell Therapy under Lymphopenic Conditions in a Murine Melanoma Model.

Yu EM, Cho E, Singh R, Kim SH, Han C, Han S, Lee DG, Kim YH, Kwon BS, Choi BK. Yu EM, et al. Among authors: kim yh, kim sh. Cells. 2021 Aug 7;10(8):2018. doi: 10.3390/cells10082018. Cells. 2021. PMID: 34440787 Free PMC article.

2

Characterization of human homologue of 4-1BB and its ligand.

Zhou Z, Kim S, Hurtado J, Lee ZH, Kim KK, Pollok KE, Kwon BS. Zhou Z, et al. Immunol Lett. 1995 Feb;45(1-2):67-73. doi: 10.1016/0165-2478(94)00227-i. Immunol Lett. 1995. PMID: 7622190

3

4-1BB signaling activates glucose and fatty acid metabolism to enhance CD8⁺ T cell proliferation.

Choi BK, Lee DY, Lee DG, Kim YH, Kim SH, Oh HS, Han C, Kwon BS. Choi BK, et al. Among authors: kim yh, kim sh. Cell Mol Immunol. 2017 Sep;14(9):748-757. doi: 10.1038/cmi.2016.02. Epub 2016 Mar 14. Cell Mol Immunol. 2017. PMID: 26972770 Free PMC article.

4

Cancer immunotherapy using tumor antigen-reactive T cells.

Choi BK, Kim SH, Kim YH, Kwon BS. Choi BK, et al. Among authors: kim yh, kim sh. Immunotherapy. 2018 Mar;10(3):235-245. doi: 10.2217/imt-2017-0130. Immunotherapy. 2018. PMID: 29370726 Review.

5

Desensitized chimeric antigen receptor T cells selectively recognize target cells with enhanced antigen expression.

Han C, Sim SJ, Kim SH, Singh R, Hwang S, Kim YI, Park SH, Kim KH, Lee DG, Oh HS, Lee S, Kim YH, Choi BK, Kwon BS. Han C, et al. Among authors: kim yh, kim yi, kim sh, kim kh. Nat Commun. 2018 Feb 1;9(1):468. doi: 10.1038/s41467-018-02912-x. Nat Commun. 2018. PMID: 29391449 Free PMC article.

6

RELT negatively regulates the early phase of the T-cell response in mice.

Choi BK, Kim SH, Kim YH, Lee DG, Oh HS, Han C, Kim YI, Jeon Y, Lee H, Kwon BS. Choi BK, et al. Among authors: kim yh, kim yi, kim sh. Eur J Immunol. 2018 Oct;48(10):1739-1749. doi: 10.1002/eji.201847633. Epub 2018 Sep 2. Eur J Immunol. 2018. PMID: 30138536 Free article.

7

Delayed IL-21 treatment preferentially expands peptide-specific CD8⁺ T cells by reducing bystander activation of T cells.

Kim SH, Park SY, Lim MC, Lee ES, Lee EG, Han SE, Kim YH, Kwon BS, Choi BK. Kim SH, et al. Among authors: kim yh. Immunotherapy. 2019 Apr;11(6):497-513. doi: 10.2217/imt-2018-0095. Epub 2019 Feb 14. Immunotherapy. 2019. PMID: 30760061

8

Polymorphic Region-Specific Antibody for Evaluation of Affinity-Associated Profile of Chimeric Antigen Receptor.

Han C, Choi BK, Kim SH, Sim SJ, Han S, Park B, Tsuchiya Y, Takahashi M, Kim YH, Eom HS, Kitaguchi T, Ueda H, Kwon BS. Han C, et al. Among authors: kim yh, kim sh. Mol Ther Oncolytics. 2020 Apr 14;17:293-305. doi: 10.1016/j.omto.2020.04.004. eCollection 2020 Jun 26. Mol Ther Oncolytics. 2020. PMID: 32368617 Free PMC article.

9

Chronic activation of 4-1BB signaling induces granuloma development in tumor-draining lymph nodes that is detrimental to subsequent CD8⁺ T cell responses.

Kim SH, Singh R, Han C, Cho E, Kim YI, Lee DG, Kim YH, Kim SS, Shin DH, You HJ, Lee HW, Kwon BS, Choi BK. Kim SH, et al. Among authors: kim yh, kim yi, kim ss. Cell Mol Immunol. 2021 Aug;18(8):1956-1968. doi: 10.1038/s41423-020-00533-3. Epub 2020 Aug 31. Cell Mol Immunol. 2021. PMID: 32868911 Free PMC article.

10

Adoptive immunotherapy with transient anti-CD4 treatment enhances anti-tumor response by increasing IL-18Rα^hi CD8⁺ T cells.

Kim SH, Cho E, Kim YI, Han C, Choi BK, Kwon BS. Kim SH, et al. Among authors: kim yi. Nat Commun. 2021 Sep 7;12(1):5314. doi: 10.1038/s41467-021-25559-7. Nat Commun. 2021. PMID: 34493727 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25,327 results

Search Page

Filters